resveratrol has been researched along with ucf 101 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hueckstaedt, LK; Li, Q; Ren, J | 1 |
| Li, J; Li, Q; Ren, J | 1 |
2 other study(ies) available for resveratrol and ucf 101
| Article | Year |
|---|---|
The protease inhibitor UCF-101 ameliorates streptozotocin-induced mouse cardiomyocyte contractile dysfunction in vitro: role of AMP-activated protein kinase.
Topics: Acetylcysteine; AMP-Activated Protein Kinases; Animals; Antioxidants; Calcium-Binding Proteins; Cardiomyopathies; Diabetes Complications; Diabetes Mellitus, Experimental; High-Temperature Requirement A Serine Peptidase 2; In Vitro Techniques; Male; MAP Kinase Signaling System; Mice; Mitochondrial Proteins; Myocardial Contraction; Myocytes, Cardiac; Protease Inhibitors; Pyrimidinones; Resveratrol; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Serine Endopeptidases; Stilbenes; Streptozocin; Thiones; X-Linked Inhibitor of Apoptosis Protein | 2009 |
UCF-101 mitigates streptozotocin-induced cardiomyocyte dysfunction: role of AMPK.
Topics: Adenylate Kinase; Animals; Antioxidants; Blood Glucose; Blotting, Western; Caspase 3; Cell Separation; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Isoenzymes; Male; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocytes, Cardiac; Phosphorylation; Protease Inhibitors; Protein Phosphatase 2; Pyrimidinones; Resveratrol; Stilbenes; Thiones | 2009 |